Westside Investment Management Inc. held its stake in Henry Schein, Inc. (NASDAQ:HSIC) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,000 shares of the company’s stock at the close of the 2nd quarter. Westside Investment Management Inc.’s holdings in Henry Schein were worth $181,000 at the end of the most recent quarter.
Several other institutional investors have also made changes to their positions in HSIC. BlackRock Inc. boosted its position in shares of Henry Schein by 2,999.6% in the first quarter. BlackRock Inc. now owns 5,595,279 shares of the company’s stock valued at $951,028,000 after acquiring an additional 5,414,761 shares during the period. Janus Henderson Group PLC boosted its position in shares of Henry Schein by 394.1% in the second quarter. Janus Henderson Group PLC now owns 1,465,303 shares of the company’s stock valued at $268,173,000 after acquiring an additional 1,168,763 shares during the period. MARSHALL WACE ASIA Ltd bought a new stake in shares of Henry Schein in the first quarter valued at about $50,281,000. Marshall Wace North America L.P. bought a new stake in shares of Henry Schein in the first quarter valued at about $50,281,000. Finally, Vanguard Group Inc. boosted its position in shares of Henry Schein by 3.0% in the second quarter. Vanguard Group Inc. now owns 8,086,317 shares of the company’s stock valued at $1,479,959,000 after acquiring an additional 236,862 shares during the period. 44.52% of the stock is owned by institutional investors.
Shares of Henry Schein, Inc. (HSIC) traded down 0.72% on Friday, reaching $80.99. The company’s stock had a trading volume of 1,075,227 shares. The firm’s 50-day moving average price is $83.51 and its 200-day moving average price is $87.53. The stock has a market cap of $12.81 billion, a P/E ratio of 23.67 and a beta of 1.08. Henry Schein, Inc. has a 12 month low of $73.11 and a 12 month high of $93.50.
Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, August 8th. The company reported $0.88 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.86 by $0.02. The firm had revenue of $3.06 billion during the quarter, compared to the consensus estimate of $3.05 billion. Henry Schein had a return on equity of 19.91% and a net margin of 4.59%. The company’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter last year, the company posted $0.82 EPS. On average, analysts forecast that Henry Schein, Inc. will post $3.64 earnings per share for the current fiscal year.
Henry Schein announced that its board has authorized a share buyback program on Monday, September 18th that permits the company to repurchase $400.00 million in shares. This repurchase authorization permits the company to buy up to 6.3% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s board of directors believes its stock is undervalued.
A number of brokerages have recently issued reports on HSIC. Zacks Investment Research cut shares of Henry Schein from a “buy” rating to a “hold” rating in a research report on Wednesday, August 9th. Northcoast Research raised shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $109.00 target price for the company in a research report on Monday, August 7th. BidaskClub cut shares of Henry Schein from a “hold” rating to a “sell” rating in a research report on Wednesday, August 2nd. Jefferies Group LLC reissued a “hold” rating and issued a $88.50 target price on shares of Henry Schein in a research report on Thursday, September 28th. Finally, Credit Suisse Group reissued a “hold” rating and issued a $80.00 target price on shares of Henry Schein in a research report on Thursday, July 13th. One analyst has rated the stock with a sell rating, eleven have assigned a hold rating and seven have assigned a buy rating to the stock. Henry Schein has a consensus rating of “Hold” and an average price target of $92.17.
In related news, SVP Paul Rose sold 2,126 shares of the business’s stock in a transaction that occurred on Wednesday, September 6th. The stock was sold at an average price of $172.51, for a total value of $366,756.26. Following the completion of the sale, the senior vice president now owns 17,841 shares in the company, valued at approximately $3,077,750.91. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.27% of the company’s stock.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.